Have a personal or library account? Click to login
Correlation between expressions of hypoxia -inducible factor (HIF-1α), blood vessels density, cell proliferation, and apoptosis intensity in canine fibromas and fibrosarcomas Cover

Correlation between expressions of hypoxia -inducible factor (HIF-1α), blood vessels density, cell proliferation, and apoptosis intensity in canine fibromas and fibrosarcomas

Open Access
|Mar 2014

References

  1. 1. Biju M.P., Neumann A.K., Bensinger S.J., Johnson R.S., Turka L.A., Haase V.H.: Vhlh gene deletion induces Hif-1- mediated cell death in thymocytes. Mol Cell Biol 2004, 24, 9038-9047.10.1128/MCB.24.20.9038-9047.2004
  2. 2. Birner P., Gatterbauer B., Oberhuber G., Schindl M., Rössler K., Prodinger A., Budka H., Hainfellner J.A.: Expression of hypoxia-inducible factor-1α in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer 2001, 92, 165-171.10.1002/1097-0142(20010701)92:1<;165::AID-CNCR1305>3.0.CO;2-F
  3. 3. Birner P., Schindl M., Obermair A., Breitenecker G., Oberhuber G.: Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 2001, 7, 1661-1668.10.1002/1097-0142(20010701)92:1<;165::AID-CNCR1305>3.0.CO;2-F
  4. 4. Birner P., Schindl M., Obermair A., Plank C., Breitenecker G., Oberhuber G.: Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000, 60, 4693-4596.
  5. 5. Blouw B., Song H., Tihan T., Bosze J., Ferrara N., Gerber H.P., Johnson R.S., Bergers G.: The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 2003, 4, 133-146.10.1016/S1535-6108(03)00194-6
  6. 6. Bos R., Zhong H., Hanrahan C.F., Mommers E.C., Semenza G.L., Pinedo H.M., Abeloff M.D., Simons J.W., van Diest P.J., van der Wall E.: Levels of hypoxia-inducible factor-1α during breast carcinogenesis. J Natl Cancer Inst 2001, 93, 309-314.10.1093/jnci/93.4.309
  7. 7. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., Keshert E.: Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998, 394, 485-490.10.1038/28867
  8. 8. Ciaputa R., Kandefer-Gola M., Nowak M., Madej J.A.: Prevalence of tumours in domestic animals in the Lower Silesia (Poland) in 2009-2011. Bull Vet Inst Pulawy 2013, 57, 53-59.10.2478/bvip-2013-0010
  9. 9. Francis P., Namløs H.M., Müller C., Edén P., Fernebro J., Berner J.M., Bjerkehagen B., Akerman M., Bendahl P.O., Isinger A., Rydholm A., Myklebost O., Nilbert M.: Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential. BMC Genomics 2007, 8, 73-89.10.1186/1471-2164-8-73
  10. 10. Guo K., Searfoss G., Krolikowski D., Pagnoni M., Franks C., Clark K., Yu K.T., Jaye M., Ivashchenko Y.: Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ 2001, 8, 367-376.10.1038/sj.cdd.4400810
  11. 11. Haberkorn U., Altmann A., Mier W., Eisenhut M.: Molecular imaging of tumor metabolism and apoptosis. Ernst Schering Found Symp Proc 2007, 4, 125-152.10.1007/2789_2008_092
  12. 12. Jiang C.Q., Fan L.F., Liu Z.S., Qian Q., Xia D., Diao L.M., He Y.M., Ai Z.L.: Expression levels and significance of hypoxia inducible factor-1α and vascular endothelial growth factor in human colorectal adenocarcinoma. Chin Med J 2004, 117, 1541-1546.
  13. 13. Jiang C.Q., Liu Z.S., Qian Q., He Y.M., Yuan Y.F., Ai Z.L.: Relationship of hypoxia-inducible factor 1α (HIF-1α) gene expression with vascular endothelial growth factor (VEGF) and microvessel density (MVD) in human colorectal adenoma and adenocarcinoma Ai Zheng. 2003, 22, 1170-1174.
  14. 14. Kang T., Ye F.C., Gao S.J., Wang L.D.: Angiogenesis, Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus. Virol Sin 2008, 23, 449-458.10.1007/s12250-008-2998-8
  15. 15. Kilic M., Kasperczyk H., Fulda S., Debatin K.M.: Role of hypoxia inducible factor-1α in modulation of apoptosis resistance. Oncogene 2007, 26, 2027-2038.10.1038/sj.onc.1210008
  16. 16. Koukourakis M.I., Giatromanolaki A., Skarlatos J., Corti L., Blandamura S., Piazza M., Gatter K.C., Harris A.L.: Hypoxia inducible factor (HIF-1α and HIF-2α) expression in early oesophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res 2001, 61, 1830-1832.
  17. 17. Maxwell P.H.: The HIF pathway in cancer. Seminars Cell Develop Biol 2005, 16, 523-530.10.1016/j.semcdb.2005.03.001
  18. 18. Ozbudak I.H., Karaveli S., Simsek T., Erdogan G., Pestereli E.: Neoangiogenesis and expression of hypoxia-inducible factor 1α, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas. Gynecol Oncol 2008, 108, 603-608.10.1016/j.ygyno.2007.11.028
  19. 19. Remmele W., Stegner H.E.: Vorschlag zur einheitlichen Definition eines immunoreaktiven Score (IRS) für den immunohistochemichen Östrogenrezeptor-Nachweis (ER-ICA) im Mammakarzinomgewebe. Pathologie 1987, 8, 138-140.
  20. 20. Savai R., Schermuly R.T., Voswinckel R., Renigunta A., Reichmann B., Eul B., Grimminger F., Seeger W., Rose F., Hänze J.: HIF-1α attenuates tumor growth in spite of augmented vascularization in an A549 adenocarcinoma mouse model. Int J Oncol 2005, 27, 393-400.10.3892/ijo.27.2.393
  21. 21. Semenza G.L.: HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 2002, 8, 62-67.10.1016/S1471-4914(02)02317-1
  22. 22. Shintani K., Matsumine A., Kusuzaki K., Matsubara T., Satonaka H., Wakabayashi T., Hoki Y., Uchida A.: Expression of hypoxia-inducible factor (HIF)-1α as a biomarker of outcome in soft-tissue sarcomas. Virchows Arch 2006, 449, 673-81.10.1007/s00428-006-0304-417103226
  23. 23. Shyu K.G., Hsu F.L., Wang M.J., Wang B.W., Lin S.: Hypoxia- inducible factor 1α regulates lung adenocarcinoma cell invasion. Exp Cell Res 2007, 313, 1181-1191.10.1016/j.yexcr.2007.01.01317335808
  24. 24. Simiantonaki N., Taxeidis M., Jayasinghe C., Kurzik-Dumke U., Kirkpatrick C.J.: Hypoxia-inducible factor 1α expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer 2008, 4, 320-333.10.1186/1471-2407-8-320258466018983642
  25. 25. Staab A., Loeffler J., Said H.M., Diehlmann D., Katzer A., Beyer M., Fleischer M., Schwab F., Baier K., Einsele H., Flentje M., Vordermark D.: Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells. BMC Cancer 2007, 7, 213-220.10.1186/1471-2407-7-213220067217999771
  26. 26. Sun H.C., Qiu Z.J., Liu J., Sun J., Jiang T., Huang K.J., Yao M., Huang C.: Expression of hypoxia-inducible factor-1α and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Int J Oncol 2007, 30, 1359-1367.10.3892/ijo.30.6.1359
  27. 27. Urano N., Fujiwara Y., Doki Y., Tsujie M., Yamamoto H., Miyata H., Takiguchi S., Yasuda T., Yano M., Monden M.: Overexpression of hypoxia-inducible factor-1α in gastric adenocarcinoma. Gastric Cancer 2006, 9, 44-49.10.1007/s10120-005-0356-116557436
  28. 28. Webb C.P., Van de Woude G.F.: Genes that regulate metastases and angiogenesis. J Neurooncol 2000, 50, 71-87.10.1023/A:1006466605356
  29. 29. Weiss S.W., Goldblum J.R.: Soft Tissue Tumors. Mosby, St. Louis, 2001, pp. 21-44.
  30. 30. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W.: Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 1999, 59, 5830-5835.
Language: English
Page range: 117 - 123
Published on: Mar 25, 2014
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2014 Janusz A. Madej, Jan P. Madej, Piotr Dzięgiel, Bartosz Puła, Marcin Nowak, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.